Format

Send to

Choose Destination
See comment in PubMed Commons below
Prion. 2011 Jul-Sep;5(3):123-5. doi: 10.4161/pri.5.3.16327. Epub 2011 Jul 1.

(Ctm)PrP and ER stress: a neurotoxic mechanism of some special PrP mutants.

Author information

1
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Abstract

The pathogenic agent is hypothesized to be PrP(Sc) in prion diseases. However, little accumulation of PrPSc is repeatedly observed in some kinds of natural and experimental prion diseases, including some special genetic human prion diseases. One of the specific topology forms of PrP, (Ctm)PrP, representing a key neurotoxic intermediate in prion disorders, has been testified in cell-free translation systems and transgenic mice models. Recently, some studies have showed that point-mutations within the hydrophobic transmembrane region increase the amount of (Ctm)PrP in cells, such as human homologue A117V which is associated with GSS and G114V associated with gCJD, while the mutations outsides transmembrane region do not. The retention of the CtmPrP in ER subsequently is able to induce ER stress and apoptosis, which is supported by up-regulation of ER chaperone synthesis, such as Grp78, Grp58, Grp94, Bip and the transcription factor CHOP/GADD153. In conclusion, some kinds of intermediate forms of PrP(Sc) , including (Ctm)PrP, may work as the ultimate cause of neurodegeneration.

PMID:
21795854
PMCID:
PMC3226035
DOI:
10.4161/pri.5.3.16327
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis Icon for PubMed Central
    Loading ...
    Support Center